Amgen 2001 Annual Report Download - page 8

Download and view the complete annual report

Please find page 8 of the 2001 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 54

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54

The capital markets are
watching. They want to
see Amgen succeed in
delivering therapeutics
that benefit patients,
advance health care, and
reward stockholders.
Investment in human
and technical capabilities
is rising along with our
growth expectations.
Amgen’s R&D investment,
in particular, reached an
industry-leading 25% of
product sales.
We are here to ensure
that Amgen gets from
A to B to C as efficiently
and effectively as possible.
From communications
to strategy to finance,
we must be a source of
support and new ideas
that can facilitate the
growth and development
of the company.
Richard Nanula Executive Vice President, Finance, Strategy, and Communications
and Chief Financial Officer
Investments Worth Making
“Scaling up Amgen to meet the demands of our tremendous
growth opportunities is a multi-faceted challenge.
It touches every part of our business and every process we have.”
6